|
Comparative genomics reveals molecular evolution of Q fever pathogen (PhysOrg)
Scientists from the National Institute of Allergy and Infectious Diseases, Texas A&M Health Center, and the Virginia Bioinformatics Institute at Virginia Tech have uncovered genetic clues about why some strains of the pathogen Coxiella burnetii are more virulent than others.
(Feb 2, 2009)
Strategic Diagnostics Appoints Monette Greenway as Vice President, Marketing and Sales (Centre Daily Times)
Strategic Diagnostics Inc. (Nasdaq: SDIX) – today announced key additions to its management team of two experienced professionals from the Life Sciences market. Monette Greenway was appointed Vice President, Marketing and Sales effective January 28, 2009, and Robert Laffer joined SDI as Sales Manager for Life Sciences effective January 15, 2009.
(Feb 2, 2009)
Cold Spring Harbor Protocols features stem cell differentiation, plant RNAi methods (EurekAlert!)
( Cold Spring Harbor Laboratory ) This month's issue of "Cold Spring Harbor Protocols" highlights methods involving RNA interference in plants and stem cell differentiation.
(Feb 2, 2009)
Fox Chase Licenses Bioinformatics Tools from BioDiscovery (GenomeWeb News)
NEW YORK (GenomeWeb News) – Fox Chase Cancer Center's Keystone Program in Blood Cell Development and Cancer has acquired a site license for two bioinformatics software programs from BioDiscovery.
(Feb 2, 2009)
Study: racial profiling no more effective than random screen (Ars Technica)
One of the larger problems facing the security industry in the era of mass terrorism is the task of creating a profile of a likely terrorist. Identifying those at risk of first time offenses is a challenge in any context, but the stakes are higher when that offense may also be the last, and involve the deaths of dozens of people. We've discussed the challenges of generating profiles of ...
(Feb 2, 2009)
PerkinElmer to Divest Proteomics Business to Concentrate on Human, Environmental Health (GenomeWeb News)
PerkinElmer plans to divest its proteomics product line and intends to focus instead on developing screening and diagnostic tools and technologies for food safety and security applications, the company said last week.
(Feb 2, 2009)
At the Forefront: Epigenomics Heats Up (GenomeWeb News)
Move over, Mendel. The age of epigenomics is here, and it's provoking a lot of interesting questions.
(Feb 2, 2009)
The Father of Cell Biology Has Died (GenomeWeb News)
Nobel laureate and one of the founding fathers of modern cell biology, George Palade, has died at 95. He was one of the first to use electron microscopy, which helped him discover the ribosome and the action of secretory proteins.
(Feb 2, 2009)
Leading futurists, thinkers to launch Silicon Valley university (CNET via Yahoo! News)
Starting this summer, some of the world's leading thinkers in exponentially growing technologies will be gathering annually at NASA Ames Research Center, in the heart of Silicon Valley, for 10 weeks of discussions on how to change the future. And you could join them.
(Feb 3, 2009)
Leading futurists, thinkers to launch Silicon Valley university (CNET)
Dubbed Singularity University, the new program, run by Ray Kurzweil and Peter Diamandis, will focus on exponentially growing technologies.
(Feb 3, 2009)
World-Renowned Scientists Team With Google And NASA To Launch Singularity University (TechCrunch)
NASA, Google, and some of the foremost authorities in science and technology have teamed up to create a new school, dubbed Singularity University , that is looking to solve "humanity's grand challenges". The university is named after the idea of the singularity - an extremely rapid period of technological progress. And damn if it doesn't sound like the coolest school ever. The roster ...
(Feb 3, 2009)
Fasudil could reduce risk of Alzheimer's (News-Medical-Net)
A drug used to improve blood flow to the brain also could help improve learning and memory and reduce the risk of Alzheimer's disease, according to a new study released today by investigators at the Translational Genomics Research Institute (TGen) and Arizona State University.
(Feb 3, 2009)
Bio-informatics can help in advancement of medical science (New Kerala)
Shillong, Feb 3 : Bio Informatics can be of tremendous help in navigating through the sea of information, Meghalaya Governor R S Mooshahary said while calling for improvement in the quality of manpower in that field.
(Feb 3, 2009)
A Singular(ity) School (Forbes)
Futurists create a place to study the fusion of ideas and science across disciplines.
(Feb 3, 2009)
New genetic clues on molecular evolution of Q fever pathogen (News-Medical-Net)
Scientists from the National Institute of Allergy and Infectious Diseases, Texas A&M Health Center, and the Virginia Bioinformatics Institute at Virginia Tech have uncovered genetic clues about why some strains of the pathogen Coxiella burnetii are more virulent than others.
(Feb 3, 2009)
Roche NimbleGen and 454 Life Sciences Capture the Targeted Resequencing Market on a Global Scale (Business Wire via Yahoo! Finance)
MADISON, Wis.----Roche NimbleGen and 454 Life Sciences are capturing the targeted resequencing market as researchers in laboratories worldwide adopt the NimbleGen Sequence Capture microarrays and the Genome Sequencer FLX System to speed sample preparation and subsequent sequencing for research on genetic-based diseases such as cancer and diabetes.
(Feb 3, 2009)
GSK To Commit $1.3 Million To Singapore Institute's Vaccine Development Projects (Medical News Today)
Singapore's Bioprocessing Technology Institute (BTI) and Glaxo SmithKline (GSK) Biologicals SA Belgium have sealed an agreement to collaborate in three vaccine and adjuvant system related research projects. Adjuvants are compounds used together with vaccines to boost a person's immune responses.
(Feb 3, 2009)
Roche NimbleGen and 454 Life Sciences Capture the Targeted Resequencing Market on a Global Scale (Centre Daily Times)
Roche NimbleGen and 454 Life Sciences are capturing the targeted resequencing market as researchers in laboratories worldwide adopt the NimbleGen Sequence Capture microarrays and the Genome Sequencer FLX System to speed sample preparation and subsequent sequencing for research on genetic-based diseases such as cancer and diabetes. Targeted resequencing allows scientists to capture only the ...
(Feb 3, 2009)
Photo Release -- Protea Releases New Proteomics Technology Platform (GlobeNewswire via Yahoo! Finance)
MORGANTOWN, W.Va., Feb. 3, 2009 -- Protea Biosciences, Inc., a leader in the development of new protein research technology, announced today the commercial launch of its new protein recovery technology platform, the GPR-800.
(Feb 3, 2009)
Stroma genomic signature predicts resistance to anthracyclin-based chemotherapy in breast cancer (EurekAlert!)
( Swiss Institute of Bioinoformatics ) Researchers at the Swiss Institute of Bioinformatics and the Swiss National Center of Competence in Research in Molecular Oncology in Lausanne have developed a new test to predict how breast cancer patients respond to chemotherapy, which could help change how treatment is delivered in the future.
(Feb 3, 2009)
Prodesse Files for FDA OK for C. Difficile Assay (GenomeWeb News)
The Milwaukee, Wis.-based firm said that it had filed for 510(k) clearance of the ProGastro Cd Assay following clinical trials conducted at several clinical labs in the US. The assay is already being used for clinical diagnostics in Europe, and additional studies of the test are currently being conducted in the UK.
(Feb 3, 2009)
Transgenomic Licenses Power3 Neuro Biomarkers (GenomeWeb News)
NEW YORK (GenomeWeb News) – Transgenomic said on Monday that it has finalized an agreement with Power3 Medical Products giving it rights to Power3' Medical's neurodegenerative biomarkers.
(Feb 3, 2009)
Researchers ID Lung Cancer Prognostic Signatures (GenomeWeb News)
NEW YORK (GenomeWeb News) – In a paper scheduled to appear online this week in the Proceedings of the National Academy of Sciences , a team of Ontario researchers used a computer algorithm to come up with a new six-gene expression signature for predicting survival in non-small cell lung cancer that they subsequently validated in four datasets.
(Feb 3, 2009)
Stroma Genomic Signature Predicts Resistance To Anthracyclin-based Chemotherapy In Breast Cancer (Science Daily)
Researchers have developed a new test to predict how breast cancer patients respond to chemotherapy, which could help change how treatment is delivered in the future.
(Feb 3, 2009)
Research and Markets: Plant Proteomics Out Now (Business Wire via Yahoo! Finance)
DUBLIN, Ireland----Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Plant Proteomics" to their offering.
(Feb 3, 2009)
Stroma genomic signature predicts resistance to anthracyclin-based chemotherapy in breast cancer (PhysOrg)
Researchers at the Swiss Institute of Bioinformatics and the Swiss National Center of Competence in Research in Molecular Oncology in Lausanne have developed a new test to predict how breast cancer patients respond to chemotherapy, which could help change how treatment is delivered in the future. In an article, 'A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in ...
(Feb 3, 2009)
CORRECTING|and REPLACING Strategic Diagnostics Appoints Monette Greenway as Vice President, Marketing and Sales (Business Wire via Yahoo! Finance)
NEWARK, Del.----Eight graph, second sentence of release dated Feb. 2, 2009, should read: Both the option and the restricted stock vest in four equal annual installments, beginning on the date of grant.
(Feb 3, 2009)
New Kid on the Block (GenomeWeb News)
Yesterday, the Coriell Personalized Medicine Collaborative website went live . Unlike its personal genomics competitors, Coriell is offering a full genome scan plus a genetic health report and genetic counseling all for free.
(Feb 3, 2009)
Finding Mutations that Protect (GenomeWeb News)
Technology Review has a Q&A with Ken Offit, chief of the clinical genetics service at Memorial Sloan-Kettering Cancer Center, who is leading a new study looking for protective variants in women with mutations in BRCA2. He hopes to use SNP arrays and a large number of study participants worldwide to find what factors might protect women who are genetically predisposed to getting breast cancer ...
(Feb 3, 2009)
Reproductive Cloning in Sight? (GenomeWeb News)
A story in Wired looks at the possibility of human cloning. In a study led by Robert Lanza, scientific director of Advanced Cell Technologies, he showed that the genes turned on in normal human embryos are the same genes turned on in human clones.
(Feb 3, 2009)
Drug That Could Reduce Risk Of Alzheimer's Discovered By TGen And ASU Researchers (Medical News Today)
A drug used to improve blood flow to the brain also could help improve learning and memory and reduce the risk of Alzheimer's disease, according to a new study released by investigators at the Translational Genomics Research Institute (TGen) and Arizona State University.
(Feb 3, 2009)
NIH Funding for Proteomics Fall 3 Percent in FY 2008 as Number of Grants Slides 8 Percent (GenomeWeb News)
For the period covering Oct.1, 2007, to Sept. 30, 2008, the NIH handed out $125.6 million in grants for proteomics research, compared to $129.1 million in fiscal 2007. Meanwhile, 317 awards were handed out in 2008, down more than 8 percent from 346 grants given in 2007. In many, if not most, cases, funding received in 2008 were part of multi-year grants that began in earlier years.
(Feb 3, 2009)
NIH Funding for Proteomics Fall 3 Percent in FY 2008 as Number of Grants Slides 8 Percent (GenomeWeb News)
For the period covering Oct.1, 2007, to Sept. 30, 2008, the NIH handed out $125.6 million in grants for proteomics research, compared to $129.1 million in fiscal 2007. Meanwhile, 317 awards were handed out in 2008, down more than 8 percent from 346 grants given in 2007. In many, if not most, cases, funding received in 2008 were part of multi-year grants that began in earlier years.
(Feb 3, 2009)
Molecular Evolution Of Q Fever Pathogen Revealed (Medical News Today)
Scientists from the National Institute of Allergy and Infectious Diseases, Texas A&M Health Center, and the Virginia Bioinformatics Institute at Virginia Tech have uncovered genetic clues about why some strains of the pathogen Coxiella burnetii are more virulent than others. The researchers compared the sequences of four different strains of C.
(Feb 3, 2009)
Helicos, Rosetta Shares Rose Sharply in January (GenomeWeb News)
NEW YORK (GenomeWeb News) – Shares of Helicos BioSciences and Rosetta Genomics rose more than 100 percent each during January to lead the 36 stocks that comprise the GenomeWeb Daily News Index.
(Feb 3, 2009)
New Products (GenomeWeb News)
CLC Bio has released version 3.0 of CLC Genomics Workbench . The new version allows users to perform digital gene expression analyses, as well as analyses of expression microarray and RNA-Seq data.
(Feb 3, 2009)
Paired Ends (GenomeWeb News)
An algorithm that researchers used to identify a new gene expression signature to predict lung cancer survival also suggests that there are thousands of such prognostic signatures in microarray data sets.
(Feb 3, 2009)
Broad Institute to Cut Sequencing Staff (GenomeWeb News)
NEW YORK (GenomeWeb News) — The Broad Institute of MIT and Harvard will cut 24 employees from its Genome Sequencing Platform because new genomics technologies have made some staff unnecessary.
(Feb 3, 2009)
BioArray Briefs (GenomeWeb News)
Fluidigm said this week that Cancer Research UK's Centre for Genetic Epidemiology, University of Cambridge, will use its EP1 system to conduct cancer research and disease-association studies.
(Feb 3, 2009)
New Product Watch (GenomeWeb News)
Navigenics last week launched Annual Insight , a direct-to-consumer genetic testing service available for $499 that provides information on an individual’s genetic predisposition for common preventable health conditions.
(Feb 3, 2009)
Funding Update (GenomeWeb News)
An algorithm that researchers used to identify a new gene expression signature to predict lung cancer survival also suggests that there are thousands of such prognostic signatures in microarray data sets.
(Feb 3, 2009)
Gentel Prepares to Launch APiX Platform, Assays in H1 as It Looks to Build Services Arm (GenomeWeb News)
Gentel Biosciences, a nine-year-old privately held protein-array firm based in Madison, Wis., is planning to launch assays for carbohydrate and cancer-biomarker profiling this month, and to debut a new high-throughput microarray platform called APiX in June, according to a company official.
(Feb 3, 2009)
Kreatech to Grow Product, Sales Efforts to Face Ever-Growing Molecular Cytogenetics Market (GenomeWeb News)
Encouraged by demand from molecular cytogeneticists for its fluorescent in situ hybridization probes and microarray labeling kits, Amsterdam-based Kreatech Diagnostics will add resources to its direct sales channels in Europe and is developing its own microRNA array product line, according to a company official.
(Feb 3, 2009)
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2008 (Centre Daily Times)
Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the fourth quarter and fiscal year 2008.
(Feb 3, 2009)
Google Backs Singularity University Vision for Leaders (NewsFactor via Yahoo! News)
After a year of working behind the scenes, technology veteran Ray Kurzweil has taken his research on singularity to the next level. Kurzweil, along with NASA's Peter Diamandis and a team of other top technologists, will launch Singularity University for leaders from all backgrounds to study singularity -- the theory that artificial intelligence will someday surpass human intelligence.
(Feb 3, 2009)
AdvanDx Gets FDA OK for Dual Pathogens Test (GenomeWeb News)
NEW YORK (GenomeWeb News) – AdvanDx has received US Food and Drug Administration clearance for its E. coli/P. aeruginosa PNA FISH assay to identify Escherichia coli and/or Pseudomonas aeruginosa directly from positive blood cultures.
(Feb 3, 2009)
The Worst Stem Cell of All (GenomeWeb News)
New York Times reports on a project set to kick off in the next few months in which three medical research centers -- the University of Michigan Comprehensive Cancer Center, Dana-Farber Cancer Institute, and Baylor College of Medicine -- will begin testing patients for the presence of cancerous stem cells to see if there's hope for therapeutically targeting them in the future.
(Feb 3, 2009)
King Tut Gets a Paternity Test (GenomeWeb News)
Egyptian archaeologists will use DNA tests to see if mummified remains of two stillborn children found in the tomb of Tutankhamun are his children, reports the BBC . DNA samples from the two fetuses will be compared to each other and to Tutankhamun at Cairo University, and the results should be known by December.
(Feb 3, 2009)
Don't Forget the Sunblock, Dear (GenomeWeb News)
Wolfgang Schreier is lead author on a paper in today's Science ($) in which a team of scientists report witnessing DNA being damaged as a result of exposure to UV light.
(Feb 3, 2009)
Agilent Technologies And National University Of Ireland, Galway, Open Biological Mass Spectrometry Facility (PharmaceuticalOnline)
Agilent Technologies Inc. and the National University of Ireland (NUI), Galway, today announced the opening of a Biological Mass Spectrometry Facility on the NUI Galway campus. The state-of-the-art facility is fully equipped with the latest accurate-mass quadrupole time-of-flight (Q-TOF) and triple quadrupole (QQQ) mass spectrometer platforms from Agilent. The facility primarily focuses on ...
(Feb 4, 2009)
|
